Sharon B. Wigal
University of California
Child Development Center
19722 MacArthur Boulevard
Irvine
USA
Name/email consistency: high
- An update on lisdexamfetamine dimesylate for the treatment of attention deficit hyperactivity disorder. Wigal, S.B., Raja, P., Shukla, A. Expert. Opin. Pharmacother (2013)
- Metabolic, toxicological, and safety considerations for drugs used to treat ADHD. Duong, S., Chung, K., Wigal, S.B. Expert. Opin. Drug. Metab. Toxicol (2012)
- Reading performance as a function of treatment with lisdexamfetamine dimesylate in elementary school children diagnosed with ADHD. Wigal, S.B., Maltas, S., Crinella, F., Stehli, A., Steinhoff, K., Lakes, K., Schuck, S. J. Atten. Disord (2012)
- Pharmacokinetic evaluation of eltoprazine. Wigal, S.B., Duong, S. Expert. Opin. Drug. Metab. Toxicol (2011)
- Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day. Wigal, S.B., Kollins, S.H., Childress, A.C., Adeyi, B. Child. Adolesc. Psychiatry. Ment. Health (2010)
- Advances in the treatment of attention-deficit/hyperactivity disorder: a guide for pediatric neurologists. Wigal, S.B., Chae, S., Patel, A., Steinberg-Epstein, R. Semin. Pediatr. Neurol (2010)
- Does prior exposure to stimulants in children with ADHD impact cardiovascular parameters from lisdexamfetamine dimesylate? Wigal, S.B., Jun, A., Wong, A.A., Stehli, A., Steinberg-Epstein, R., Lerner, M.A. Postgrad. Med (2010)
- A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder. Wigal, S.B., Kollins, S.H., Childress, A.C., Squires, L. Child. Adolesc. Psychiatry. Ment. Health (2009)
- Pharmacokinetics of methylphenidate in preschoolers with attention-deficit/hyperactivity disorder. Wigal, S.B., Gupta, S., Greenhill, L., Posner, K., Lerner, M., Steinhoff, K., Wigal, T., Kapelinski, A., Martinez, J., Modi, N.B., Stehli, A., Swanson, J. J. Child. Adolesc. Psychopharmacol (2007)
- Hematologic and blood biochemistry monitoring during methylphenidate treatment in children with attention-deficit/hyperactivity disorder: 2-year, open-label study results. Wigal, S.B., Wilens, T.E., Wolraich, M., Lerner, M. Pediatrics (2007)
- The laboratory school protocol: its origin, use, and new applications. Wigal, S.B., Wigal, T.L. J. Atten. Disord (2006)
- A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder. Wigal, S.B., McGough, J.J., McCracken, J.T., Biederman, J., Spencer, T.J., Posner, K.L., Wigal, T.L., Kollins, S.H., Clark, T.M., Mays, D.A., Zhang, Y., Tulloch, S.J. J. Atten. Disord (2005)
- A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder. Wigal, S., Swanson, J.M., Feifel, D., Sangal, R.B., Elia, J., Casat, C.D., Zeldis, J.B., Conners, C.K. J. Am. Acad. Child. Adolesc. Psychiatry (2004)